We narrowed to 258 results for: Son

1. pAAV_BiCHATe27_dTomato_nlsdTomato (AAV PHP.eB)

   Viral Prep

   #213829-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV_BiCHATe27_dTomato_nlsdTomato (#213829). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_dTomato_nlsdTomato plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Promoter

   Tags

   dTomato

   Available since

   Dec. 2, 2024

   Availability

   Academic Institutions and Nonprofits only

2. pAAV_BiLAMP5e3_ChR2_mCherry (AAV PHP.eB)

   Viral Prep

   #213915-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV_BiLAMP5e3_ChR2_mCherry (#213915). In addition to the viral particles, you will also receive purified pAAV_BiLAMP5e3_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the Lamp5 interneuron-targeting enhancer E3. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Promoter

   Tags

   mCherry

   Available since

   Dec. 2, 2024

   Availability

   Academic Institutions and Nonprofits only

3. pAAV_BiCHATe27_ChR2_mCherry (AAV PHP.eB)

   Viral Prep

   #213830-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV_BiCHATe27_ChR2_mCherry (#213830). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Promoter

   Tags

   mCherry

   Available since

   Dec. 2, 2024

   Availability

   Academic Institutions and Nonprofits only

4. pAAV_BiPVe4_ChR2_mCherry (AAV PHP.eB)

   Viral Prep

   #213937-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV_BiPVe4_ChR2_mCherry (#213937). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the chandelier cell-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Promoter

   Tags

   mCherry

   Available since

   Dec. 2, 2024

   Availability

   Academic Institutions and Nonprofits only

5. pAAV.TBG.PI.eGFP.WPRE.bGH (AAV8)

   Viral Prep

   #105535-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV.TBG.PI.eGFP.WPRE.bGH (#105535). In addition to the viral particles, you will also receive purified pAAV.TBG.PI.eGFP.WPRE.bGH plasmid DNA. TBF-driven eGFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   TBG

   Tags

   EGFP

   Available since

   April 30, 2018

   Availability

   Academic Institutions and Nonprofits only

6. pENN.AAV.CMVs.Pl.Cre.rBG (AAV9)

   Viral Prep

   #105537-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CMV

   Tags

   None

   Available since

   June 29, 2018

   Availability

   Academic Institutions and Nonprofits only

7. pAAV.TBG.PI.Null.bGH (AAV8)

   Viral Prep

   #105536-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV.TBG.PI.Null.bGH (#105536). In addition to the viral particles, you will also receive purified pAAV.TBG.PI.Null.bGH plasmid DNA. AAV vector with TBG promoter. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   TBG

   Tags

   None

   Available since

   July 27, 2018

   Availability

   Academic Institutions and Nonprofits only

8. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV2)

   Viral Prep

   #105530-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CMV

   Tags

   EGFP

   Available since

   June 29, 2018

   Availability

   Academic Institutions and Nonprofits only

9. pAAV.GFAP.eGFP.WPRE.hGH (AAV5)

   Viral Prep

   #105549-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV.GFAP.eGFP.WPRE.hGH (#105549). In addition to the viral particles, you will also receive purified pAAV.GFAP.eGFP.WPRE.hGH plasmid DNA. GFAP-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   GFAP

   Tags

   EGFP

   Available since

   April 6, 2018

   Availability

   Academic Institutions and Nonprofits only

10. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV9)

    Viral Prep

    #105530-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    EGFP

    Available since

    July 13, 2018

    Availability

    Academic Institutions and Nonprofits only

11. pENN.AAV.cTNT.PI.eGFP.WPRE.rBG (AAV9)

    Viral Prep

    #105543-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pENN.AAV.cTNT.PI.eGFP.WPRE.rBG (#105543). In addition to the viral particles, you will also receive purified pENN.AAV.cTNT.PI.eGFP.WPRE.rBG plasmid DNA. cTNT-driven eGFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    cTNT

    Tags

    EGFP

    Available since

    July 24, 2018

    Availability

    Academic Institutions and Nonprofits only

12. pENN.AAV.CMVs.Pl.Cre.rBG (AAV5)

    Viral Prep

    #105537-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    None

    Available since

    Feb. 7, 2025

    Availability

    Academic Institutions and Nonprofits only

13. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV1)

    Viral Prep

    #105530-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    EGFP

    Available since

    March 26, 2019

    Availability

    Academic Institutions and Nonprofits only

14. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV5)

    Viral Prep

    #105530-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    EGFP

    Available since

    June 1, 2018

    Availability

    Academic Institutions and Nonprofits only

15. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV8)

    Viral Prep

    #105530-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    EGFP

    Available since

    June 29, 2018

    Availability

    Academic Institutions and Nonprofits only

16. pENN.AAV.CMVs.Pl.Cre.rBG (AAV1)

    Viral Prep

    #105537-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    None

    Available since

    June 29, 2018

    Availability

    Academic Institutions and Nonprofits only

17. pENN.AAV.EF1a.eGFP.WPRE.rBG (AAV2)

    Viral Prep

    #105547-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pENN.AAV.EF1a.eGFP.WPRE.rBG (#105547). In addition to the viral particles, you will also receive purified pENN.AAV.EF1a.eGFP.WPRE.rBG plasmid DNA. EF1a-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    EF1a

    Tags

    EGFP

    Available since

    Oct. 18, 2021

    Availability

    Academic Institutions and Nonprofits only

18. pENN.AAV.CMVs.Pl.Cre.rBG (AAV2)

    Viral Prep

    #105537-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    None

    Available since

    Sept. 18, 2018

    Availability

    Academic Institutions and Nonprofits only

19. pENN.AAV.hSyn.TurboRFP.WPRE.RBG (AAV1)

    Viral Prep

    #105552-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pENN.AAV.hSyn.TurboRFP.WPRE.RBG (#105552). In addition to the viral particles, you will also receive purified pENN.AAV.hSyn.TurboRFP.WPRE.RBG plasmid DNA. hSynapsin-driven TurboRFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    Syn

    Tags

    TurboRFP

    Available since

    July 25, 2018

    Availability

    Academic Institutions and Nonprofits only

20. pENN.AAV.CMVs.Pl.Cre.rBG (AAV8)

    Viral Prep

    #105537-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pENN.AAV.CMVs.Pl.Cre.rBG (#105537). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.Pl.Cre.rBG plasmid DNA. CMV-driven Cre. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    CMV

    Tags

    None

    Available since

    Dec. 14, 2018

    Availability

    Academic Institutions and Nonprofits only